Monday, July 14, 2025 | 11:19 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

EU could give conditional nod to Moderna vaccine as early as December

The extraordinary results have sparked euphoria as the unprecedented compression of vaccine development timelines from years to months looks to be paying off

Moderna
premium

This week, Moderna said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial

Jinshan Hong | Bloomberg
BioNTech SE and Moderna Inc. could receive conditional European Union marketing authorization for their Covid-19 vaccines in the second half of next month, according to the head of the EU’s executive arm, putting the bloc on track to start distributing the shots at the same time as the U.S.
 
The European Medicines Agency is in daily contact with the U.S. Food and Drug Administration about the evaluation of the vaccines in order to “synchronize” assessment, said European Commission President Ursula von der Leyen. The EMA has said conditional approval could come as early as the second half of December, von